CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway

Su-Su Zheng,Jing-Fang Wu,Wei-Xun Wu,Jin-Wu Hu,Dai Zhang,Cheng Huang,Bo-Heng Zhang
DOI: https://doi.org/10.1007/s12072-024-10696-0
IF: 9.029
2024-05-22
Hepatology International
Abstract:Chromobox Homolog 1 (CBX1) plays a crucial role in the pathogenesis of numerous diseases, including the evolution and advancement of diverse cancers. The role of CBX1 in pan-cancer and its mechanism in hepatocellular carcinoma (HCC), however, remains to be further investigated.
gastroenterology & hepatology
What problem does this paper attempt to address?